Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Leonard

Showing results (171-180 of 177) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 177 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
Potentiation of cisplatin by alpha-interferon in advanced non-small cell lung cancer (NSCLC): a phase II studyA Bowman, R J Fergusson, S G Allan, et al.
Hematological Oncology|January 1, 1989
Lomustine, vindesine and bleomycin (LVB) used in the treatment of relapsed advanced Hodgkin's disease. A prospective study on behalf of the East of Scotland and Newcastle Lymphoma Group (ESNLG)A L Lennard, S J Proctor, A A Dawson, et al.
BMJ (Clinical Research Ed.)|November 5, 1997
More money is needed to care for patients with cancerR C Leonard, I E Smith, R E Coleman, et al.
European Journal of Haematology. Supplementum|August 7, 2001
High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacyS J Proctor, P R Taylor, B Angus, et al.
British Journal of Cancer|December 1, 1996
High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast GroupD A Cameron, J Craig, H Gabra, et al.
Leukemia & Lymphoma|October 24, 2000
High dose ifosfamide in combination with etoposide and epirubicin followed by autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacyG H Jackson, B Angus, P J Carey, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma GroupD A Cameron, J M White, S J Proctor, et al.
Pageof 18

Showing results (171-180 of 177) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 177 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
Potentiation of cisplatin by alpha-interferon in advanced non-small cell lung cancer (NSCLC): a phase II studyA Bowman, R J Fergusson, S G Allan, et al.
Hematological Oncology|January 1, 1989
Lomustine, vindesine and bleomycin (LVB) used in the treatment of relapsed advanced Hodgkin's disease. A prospective study on behalf of the East of Scotland and Newcastle Lymphoma Group (ESNLG)A L Lennard, S J Proctor, A A Dawson, et al.
BMJ (Clinical Research Ed.)|November 5, 1997
More money is needed to care for patients with cancerR C Leonard, I E Smith, R E Coleman, et al.
European Journal of Haematology. Supplementum|August 7, 2001
High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacyS J Proctor, P R Taylor, B Angus, et al.
British Journal of Cancer|December 1, 1996
High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast GroupD A Cameron, J Craig, H Gabra, et al.
Leukemia & Lymphoma|October 24, 2000
High dose ifosfamide in combination with etoposide and epirubicin followed by autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacyG H Jackson, B Angus, P J Carey, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma GroupD A Cameron, J M White, S J Proctor, et al.
Pageof 18